Industry still cares about switching
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Industry was “absolutely interested in switches”, insisted Dirk Ossenberg-Engels, head of Bayer Consumer Health’s Europe South, Central Eastern Europe and Middle East business unit, after the sector’s commitment to prescription-to-OTC reclassification was challenged by Christa Wirthumer-Hoche, chair of the management board of the European Medicines Agency (EMA).
You may also be interested in...
An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process
In Part 2 of this exclusive interview, Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, tells HBW Insight what the association is doing to improve the prescription-to-OTC switch process in Germany.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.